Clinical Trials · NCT00887354
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 224
- Start date
- Apr 2009
- Locations
- 28 sites, 12 countries
- Primary endpoint
- Change in Lumbar Spine Areal Bone Mineral Density (BMD)